Cargando…
Medicare and Private Insurance Variations in New Medical Technology: The Case of Drug Eluting Stents
IMPORTANCE: Little is known about the geographic and hospital variations of the new medical technologies in Medicare. Even less is known about these variations for the privately insured. OBJECTIVE: To examine geographic and hospital variations in the diffusion of drug eluting stents, comparing Medic...
Autores principales: | Bayindir, Esra Eren, Mandic, Pinar Karaca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975559/ https://www.ncbi.nlm.nih.gov/pubmed/27500283 |
Ejemplares similares
-
Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
por: Jena, Anupam B, et al.
Publicado: (2014) -
Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021) -
Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021) -
Medicare Influence on Private Insurance: Good or Ill?
por: Jones, Stanley B.
Publicado: (1996) -
Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)